Monash IVF Group (MNIVF) Stock Price, News & Analysis

Company Overview

Monash IVF Group is an Australia-based provider of assisted reproductive and fertility services, focusing on the diagnosis and treatment of infertility through advanced clinical methodologies. The company applies evidence-based protocols and personalized care to support individuals and couples on their family-building journeys.

The company’s core offerings encompass in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), egg and embryo cryopreservation, and pre-implantation genetic screening and diagnosis (PGS/PGD). Monash IVF also operates donor egg and sperm programs, provides fertility preservation for medical and elective purposes, and delivers specialist consultations in reproductive endocrinology and gynecology. Its on-site laboratories feature high-resolution microscopy, cryogenic storage, and molecular genetic testing capabilities.

Headquartered in Melbourne, Monash IVF maintains a network of clinics and laboratories across Australia and New Zealand, ensuring comprehensive treatment pathways from initial assessment through to pregnancy monitoring. The group collaborates with healthcare professionals, academic institutions, and research bodies to drive innovation in reproductive science. Multidisciplinary teams—including embryologists, genetic counselors, fertility nurses, and specialized support staff—guide patients at each stage of care.

Beyond direct patient services, Monash IVF Group engages in research and educational initiatives designed to improve clinical outcomes and expand access to fertility care. The company continually invests in new technologies, staff training, and data-driven protocols to uphold its position as a leading reproductive health services provider in its region.

Key Stats

• Today's Range: $0.40 to $0.40
• 50-Day Range: $0.40 to $0.40
• 52-Week Range: $0.40 to $0.51
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MNIVF Stock Analysis - Frequently Asked Questions

How have MNIVF shares performed this year?

Monash IVF Group's stock was trading at $0.74 on January 1st, 2025. Since then, MNIVF shares have decreased by 45.9% and is now trading at $0.40.

How do I buy shares of Monash IVF Group?

Shares of MNIVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Hospital & Nursing Management
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MNIVF
• CIK: N/A
• Web: www.monashivfgroup.com.au
• Phone: 61.3.9420.8235
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A